After participating in this webinar, the learner will be able to:

1. Discussing pulmonary infections (PCP PCR vs DFA vs both; GM vs asp PCR or fungal panel PCR, metagenomic sequencing, and host response)
2. Discussing transplant viruses (CMV, BK, adeno)
3. Discussing respiratory and GI panels
4. Discussing the detection of pathogens through sequencing of microbial cell-free DNA

After participating in this webinar, the learner will be able to:

1. Describe the background and potential applications of telemedicine in transplantation.
2. Identify possible barriers to widespread implementation of telemedicine prior to COVID-19.
3. Discuss recent changes in regulatory barriers and telemedicine use in the COVID-19 era.
4. Describe common mHealth applications used to manage medications and how these can potentially be used by transplant patients to improve adherence and reduce medication errors.
5. Explain how dashboards can improve the efficient and effective monitoring of high-risk populations, including transplant recipients.

1. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for heart transplantation
2. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for lung transplantation
3. Describe future directions for utilization of HCV donors (NAT+/-) for thoracic organ transplantation

1. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for liver transplantation
2. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for kidney transplantation
3. Describe future directions for utilization of HCV donors (NAT+/-) for abdominal organ transplantation

1. Describe the nature of disparities in transplantation in the US
2. Identify factors that are driving disparities in transplantation - using kidney transplantation as a case study
3. Highlight examples of multi-level strategies to address disparities in transplantation

After participating in this webinar, the learner will be able to:

1. Describe the prevalence and impact of non-adherence in the solid organ transplant population.
2. Review types of technology to optimize transplant education, manage polypharmacy and increase adherence.
3. Identify technology related barriers, challenges and real-world strategies to improve use in clinical practice.

After participating in this webinar, the learner will be able to:

1. Recognize current methodologies and clinical indications for intragraft gene expression testing.
2. Describe new opportunities afforded by emerging FFPE-based intragraft gene expression technologies.
3. Understand the available data on the use of donor-derived cell-free DNA for solid organ transplants (kidney, pancreas, liver, heart, lung).
4. Understand the limitations and future directions of available data on the use of donor-derived cell-free DNA for solid organ transplants.
5. Explain the use of urine as a surrogate for kidney allograft biopsy.
6. Discuss strategies to develop and validate robust biomolecular markers of kidney allograft status.
7. Describe urinary cell biomolecular markers of human kidney allograft status.

After participating in this webinar, the learner will be able to:

1. Describe implementation and optimization of vaccination in the pre- and post-transplant settings.
2. Review current recommendations for vaccination of the transplant population.
3. Recognize the pipeline of vaccine development that impacts transplant patients including COVID vaccines.

After participating in this webinar, the learner will be able to:

• Identify different types of performance measures.
• Define components of performance measures to ensure purposeful and meaningful data.
• Describe how to analyze and interpret data to evaluate performance.
• Discuss transplant-specific performance measures and how we can use them to improve care.

After participating in this webinar, the learner will be able to:

1. Educate the transplant community on the current understanding of frailty both pre and post solid organ transplantation.
2. Establish a common nomenclature for frailty within solid organ transplantation
3. Establish recommendations for the assessment of frailty in solid organ transplant candidates
4. Establish guidelines for including a frailty assessment in candidate selection